Wednesday, July 8, 2026

pharma · Clostridium Difficile Infection · Ulcerative Colitis · MCRB

Seres Therapeutics

Seres Therapeutics patent portfolio — 36 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Cambridge, USA HQ
2010 Founded
129 Employees
Public company Type
MCRB · NYSE Ticker
Company details
Status
Public
HQ
Cambridge, USA
Founded
2010
Employees
129
Programs
8
Drugs
7
Patents
36
Intelligence · Patents

Seres Therapeutics patents

36 pharmaceutical patents indexed for Seres Therapeutics. 0 expire within 24 months.

Seres Therapeutics has 36 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 12409197

    Synergistic bacterial compositions and methods of production and use thereof

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 12214002

    Compositions and methods for treating antibiotic resistance

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 12083151

    Synergistic bacterial compositions and methods of production and use thereof

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 11918612

    Synergistic bacterial compositions and methods of production and use thereof

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 11730775

    Methods for treatment of Clostridium difficile infection or recurrence or symptoms thereof

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 11701394

    Compositions and methods for treating cholestatic disease

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 11666612

    Network-based microbial compositions and methods

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 11464812

    Synergistic bacterial compositions and methods of production and use thereof

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 11458173

    Synergistic bacterial compositions and methods of production and use thereof

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 11458174

    Synergistic bacterial compositions and methods of production and use thereof

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 11389490

    Synergistic bacterial compositions and methods of production and use thereof

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 11266699

    Synergistic bacterial compositions and methods of production and use thereof

    Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 11185562

    Compositions and methods for inhibition of pathogenic bacterial growth

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 10973861

    Compositions and methods

    Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 10967011

    Compositions and methods

    Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 10881696

    Network-based microbial compositions and methods

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 10864235

    Synergistic bacterial compositions and methods of production and use thereof

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 10258655

    Synergistic bacterial compositions and methods of production and use thereof

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 10076546

    Network-based microbial compositions and methods

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 10064900

    Methods of populating a gastrointestinal tract

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 10064901

    Compositions and methods

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 9956282

    Bacterial compositions and methods of use thereof for treatment of immune system disorders

    Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 9855303

    Compositions and methods

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 9757483

    Labeled iodinated tropane formulation

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 9585921

    Compositions and methods

    Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 9533014

    Synergistic bacterial compositions and methods of production and use thereof

    Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 9446080

    Compositions and methods

    Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 9180147

    Compositions and methods

    Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 9028841

    Synergistic bacterial compositions and methods of production and use thereof

    Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 9011834

    Compositions and methods

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 8986653

    Labeled iodinated tropane formulation

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 8906668

    Synergistic bacterial compositions and methods of production and use thereof

    Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 8574545

    Labeled iodinated tropane formulation

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 8133861

    Systemic purine administration: modulating axonal outgrowth of central nervous system neurons

    Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 8084018

    Methods for imaging dopamine transporter level

    Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7452866

    Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1

    Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Seres Therapeutics have?

36 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Seres Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.